Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3432132 | American Journal of Obstetrics and Gynecology | 2016 | 6 Pages |
Abstract
Maternal history of intravenous drug abuse is associated with an increased risk of alloimmunization. Approximately 1Â in 30 intravenous drug abuse women may be diagnosed with an alloantibody in pregnancy. Given the current US opioid epidemic, increased vigilance in screening is required. Needle-sharing represents a possible mechanism for intravenous drug abuse-associated alloimmunization; however, limited obstetric care, failure to obtain Rh immunoglobulin, or failure to identify early pregnancy loss cannot be excluded.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Justin R. MD, Sydney BA, Kelly S. MD, Mona DO, MPH, Jennifer L. MD, MPH,